

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.68236582 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.60373849 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.34165961 |
| 4 | layer formation in cerebral cortex (GO:0021819) | 5.20806027 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.15050420 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.13456341 |
| 7 | vocalization behavior (GO:0071625) | 5.10167478 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.05467934 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.04026149 |
| 10 | locomotory exploration behavior (GO:0035641) | 4.81537754 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.81411804 |
| 12 | protein localization to synapse (GO:0035418) | 4.78057518 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.74654987 |
| 14 | glutamate secretion (GO:0014047) | 4.70019024 |
| 15 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.62916493 |
| 16 | exploration behavior (GO:0035640) | 4.36690260 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.31719156 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.24023748 |
| 19 | neuron recognition (GO:0008038) | 4.17814528 |
| 20 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.17602603 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.14796310 |
| 22 | dendritic spine morphogenesis (GO:0060997) | 4.13817783 |
| 23 | glutamate receptor signaling pathway (GO:0007215) | 4.01863564 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.98133949 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.97091571 |
| 26 | neurotransmitter secretion (GO:0007269) | 3.96248581 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 3.90280964 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 3.86506215 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 3.81111625 |
| 30 | axonal fasciculation (GO:0007413) | 3.80313212 |
| 31 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.71465609 |
| 32 | proline transport (GO:0015824) | 3.71278366 |
| 33 | neuronal action potential propagation (GO:0019227) | 3.59616243 |
| 34 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.58762575 |
| 35 | establishment of mitochondrion localization (GO:0051654) | 3.58242726 |
| 36 | positive regulation of synapse maturation (GO:0090129) | 3.57571001 |
| 37 | dendrite morphogenesis (GO:0048813) | 3.56194036 |
| 38 | neurofilament cytoskeleton organization (GO:0060052) | 3.50163073 |
| 39 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.46465505 |
| 40 | behavioral response to nicotine (GO:0035095) | 3.46389120 |
| 41 | postsynaptic membrane organization (GO:0001941) | 3.44455973 |
| 42 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.43902062 |
| 43 | activation of protein kinase A activity (GO:0034199) | 3.43109539 |
| 44 | positive regulation of membrane potential (GO:0045838) | 3.42999267 |
| 45 | long-term memory (GO:0007616) | 3.41308222 |
| 46 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.39499998 |
| 47 | regulation of postsynaptic membrane potential (GO:0060078) | 3.37320831 |
| 48 | membrane depolarization during action potential (GO:0086010) | 3.35652996 |
| 49 | response to histamine (GO:0034776) | 3.34985192 |
| 50 | transmission of nerve impulse (GO:0019226) | 3.34006147 |
| 51 | gamma-aminobutyric acid transport (GO:0015812) | 3.32925662 |
| 52 | cell migration in hindbrain (GO:0021535) | 3.32574642 |
| 53 | synaptic vesicle endocytosis (GO:0048488) | 3.31954125 |
| 54 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.31288079 |
| 55 | detection of calcium ion (GO:0005513) | 3.30588520 |
| 56 | regulation of vesicle fusion (GO:0031338) | 3.30082566 |
| 57 | vesicle transport along microtubule (GO:0047496) | 3.26770494 |
| 58 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.26253196 |
| 59 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.26087455 |
| 60 | presynaptic membrane assembly (GO:0097105) | 3.25708830 |
| 61 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.23830870 |
| 62 | regulation of synaptic plasticity (GO:0048167) | 3.23548678 |
| 63 | organelle transport along microtubule (GO:0072384) | 3.23109733 |
| 64 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.22018255 |
| 65 | neurotransmitter transport (GO:0006836) | 3.21483626 |
| 66 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.21338611 |
| 67 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.20533841 |
| 68 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.19306558 |
| 69 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.18337117 |
| 70 | mechanosensory behavior (GO:0007638) | 3.18026985 |
| 71 | innervation (GO:0060384) | 3.16703411 |
| 72 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.16383626 |
| 73 | synapse assembly (GO:0007416) | 3.16292018 |
| 74 | negative regulation of microtubule polymerization (GO:0031115) | 3.13402166 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 3.12303307 |
| 76 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.11259059 |
| 77 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.09849408 |
| 78 | auditory behavior (GO:0031223) | 3.09841975 |
| 79 | intraspecies interaction between organisms (GO:0051703) | 3.08230038 |
| 80 | social behavior (GO:0035176) | 3.08230038 |
| 81 | long-term synaptic potentiation (GO:0060291) | 3.08225671 |
| 82 | neuronal action potential (GO:0019228) | 3.07298251 |
| 83 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.06657232 |
| 84 | glycosphingolipid biosynthetic process (GO:0006688) | 3.05745987 |
| 85 | short-term memory (GO:0007614) | 3.05538607 |
| 86 | behavioral fear response (GO:0001662) | 3.04120878 |
| 87 | behavioral defense response (GO:0002209) | 3.04120878 |
| 88 | positive regulation of synapse assembly (GO:0051965) | 3.03577089 |
| 89 | dopamine receptor signaling pathway (GO:0007212) | 3.03536594 |
| 90 | neuromuscular synaptic transmission (GO:0007274) | 3.02391993 |
| 91 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.02340656 |
| 92 | prepulse inhibition (GO:0060134) | 3.00354827 |
| 93 | membrane hyperpolarization (GO:0060081) | 2.99908614 |
| 94 | presynaptic membrane organization (GO:0097090) | 2.99656358 |
| 95 | membrane depolarization (GO:0051899) | 2.99487020 |
| 96 | cellular potassium ion homeostasis (GO:0030007) | 2.98601922 |
| 97 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.97938827 |
| 98 | nucleobase catabolic process (GO:0046113) | 2.97855070 |
| 99 | positive regulation of neurotransmitter transport (GO:0051590) | 2.96724404 |
| 100 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.96380111 |
| 101 | neuromuscular process controlling balance (GO:0050885) | 2.96002935 |
| 102 | dendritic spine organization (GO:0097061) | 2.95987287 |
| 103 | behavioral response to ethanol (GO:0048149) | 2.95873225 |
| 104 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.94952497 |
| 105 | response to auditory stimulus (GO:0010996) | 2.94579319 |
| 106 | startle response (GO:0001964) | 2.94401412 |
| 107 | regulation of dendritic spine development (GO:0060998) | 2.92640538 |
| 108 | regulation of neurotransmitter levels (GO:0001505) | 2.92341300 |
| 109 | positive regulation of dendritic spine development (GO:0060999) | 2.91471335 |
| 110 | cerebellum development (GO:0021549) | 2.89990013 |
| 111 | fear response (GO:0042596) | 2.89665479 |
| 112 | C4-dicarboxylate transport (GO:0015740) | 2.89588196 |
| 113 | learning (GO:0007612) | 2.88822946 |
| 114 | adult walking behavior (GO:0007628) | 2.88526579 |
| 115 | positive regulation of mitochondrial fission (GO:0090141) | 2.88128279 |
| 116 | regulation of neurotransmitter transport (GO:0051588) | 2.87460284 |
| 117 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.87348954 |
| 118 | synapse organization (GO:0050808) | 2.86031667 |
| 119 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.85401849 |
| 120 | regulation of feeding behavior (GO:0060259) | 2.77038098 |
| 121 | mitochondrion transport along microtubule (GO:0047497) | 2.76399870 |
| 122 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.76399870 |
| 123 | synaptic transmission (GO:0007268) | 2.71436214 |
| 124 | adult behavior (GO:0030534) | 2.67497918 |
| 125 | retinal cone cell development (GO:0046549) | 2.66529427 |
| 126 | serotonin metabolic process (GO:0042428) | 2.65447898 |
| 127 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.61464991 |
| 128 | regulation of synapse maturation (GO:0090128) | 2.59834303 |
| 129 | neuronal ion channel clustering (GO:0045161) | 2.57956035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.42457862 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.56230606 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.88165344 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.83636438 |
| 5 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.80024081 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.71576825 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.49337187 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.44668480 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.44668480 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.39154840 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.36147479 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.34443957 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.33529908 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31648879 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.26735982 |
| 16 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.17870832 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.16378313 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.14779932 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.14655637 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.13664245 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.09926836 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07730973 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.06544775 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05645065 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05519125 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.02570153 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.97966872 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.92156081 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88926798 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.87974330 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.78674800 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72525097 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68700150 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.64847564 |
| 35 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.60781206 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60512112 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59343314 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.55603796 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.54699145 |
| 40 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.50599205 |
| 41 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.42893133 |
| 42 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42886384 |
| 43 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42186458 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.40893022 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39732253 |
| 46 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39148872 |
| 47 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38892450 |
| 48 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.38886914 |
| 49 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.37937619 |
| 50 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37012864 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36550711 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35501132 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34944971 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.34385292 |
| 55 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33034853 |
| 56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31442743 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30090892 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28716699 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26906614 |
| 60 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.26772987 |
| 61 | EWS_26573619_Chip-Seq_HEK293_Human | 1.26706236 |
| 62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24188330 |
| 63 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23986654 |
| 64 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23793822 |
| 65 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.23793822 |
| 66 | AR_19668381_ChIP-Seq_PC3_Human | 1.23292701 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.22677414 |
| 68 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21811229 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20363608 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20123827 |
| 71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17791432 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17621352 |
| 73 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16461069 |
| 74 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.16373623 |
| 75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15903202 |
| 76 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15884189 |
| 77 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14952290 |
| 78 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14952290 |
| 79 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14154669 |
| 80 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13651410 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.13005981 |
| 82 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12646070 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12178616 |
| 84 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10749817 |
| 85 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.10160414 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09751098 |
| 87 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09435778 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08383588 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07710660 |
| 90 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.07236387 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07029955 |
| 92 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04675760 |
| 93 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04522326 |
| 94 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04425604 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03942937 |
| 96 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03598118 |
| 97 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.03024093 |
| 98 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02968157 |
| 99 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.02868779 |
| 100 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00984807 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00835831 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00807921 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00759707 |
| 104 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00106356 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99951855 |
| 106 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99926077 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99649980 |
| 108 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98431481 |
| 109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98058503 |
| 110 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97833723 |
| 111 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97714215 |
| 112 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.97141444 |
| 113 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96647533 |
| 114 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96061923 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94873935 |
| 116 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93810422 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91369271 |
| 118 | * JUN_21703547_ChIP-Seq_K562_Human | 0.91019940 |
| 119 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.90472664 |
| 120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90319404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.90225214 |
| 2 | MP0003880_abnormal_central_pattern | 4.64243889 |
| 3 | MP0004270_analgesia | 4.11941083 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.03366504 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.30373428 |
| 6 | MP0009745_abnormal_behavioral_response | 3.12762318 |
| 7 | MP0002734_abnormal_mechanical_nocicepti | 2.79542169 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.78229648 |
| 9 | MP0002064_seizures | 2.77722752 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.77219405 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.76579459 |
| 12 | MP0009046_muscle_twitch | 2.48258051 |
| 13 | MP0001486_abnormal_startle_reflex | 2.43707295 |
| 14 | MP0000778_abnormal_nervous_system | 2.32281781 |
| 15 | MP0002272_abnormal_nervous_system | 2.30998521 |
| 16 | MP0002822_catalepsy | 2.25970859 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.21833799 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.20977463 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.20102473 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.18768247 |
| 21 | MP0002184_abnormal_innervation | 2.10678093 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.07106259 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.05622616 |
| 24 | MP0001970_abnormal_pain_threshold | 2.00976716 |
| 25 | MP0003787_abnormal_imprinting | 2.00622290 |
| 26 | MP0002557_abnormal_social/conspecific_i | 1.93859067 |
| 27 | MP0004924_abnormal_behavior | 1.93501491 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.93501491 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.92916369 |
| 30 | MP0002736_abnormal_nociception_after | 1.91803029 |
| 31 | MP0002067_abnormal_sensory_capabilities | 1.91643693 |
| 32 | MP0001984_abnormal_olfaction | 1.85070586 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.82727459 |
| 34 | MP0001529_abnormal_vocalization | 1.77314813 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.72656827 |
| 36 | MP0000955_abnormal_spinal_cord | 1.68792401 |
| 37 | MP0003329_amyloid_beta_deposits | 1.64668798 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.58198860 |
| 39 | MP0008569_lethality_at_weaning | 1.55130372 |
| 40 | MP0003879_abnormal_hair_cell | 1.54936129 |
| 41 | MP0001188_hyperpigmentation | 1.53282253 |
| 42 | MP0003195_calcinosis | 1.50415066 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.49753500 |
| 44 | MP0004858_abnormal_nervous_system | 1.49324097 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.45391972 |
| 46 | MP0004885_abnormal_endolymph | 1.39721434 |
| 47 | MP0002066_abnormal_motor_capabilities/c | 1.38868330 |
| 48 | MP0003122_maternal_imprinting | 1.33726098 |
| 49 | MP0001905_abnormal_dopamine_level | 1.32964737 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.31688717 |
| 51 | MP0002152_abnormal_brain_morphology | 1.29362677 |
| 52 | MP0005499_abnormal_olfactory_system | 1.27855396 |
| 53 | MP0005394_taste/olfaction_phenotype | 1.27855396 |
| 54 | MP0010386_abnormal_urinary_bladder | 1.16928061 |
| 55 | MP0000631_abnormal_neuroendocrine_gland | 1.11792367 |
| 56 | MP0005187_abnormal_penis_morphology | 1.03973466 |
| 57 | MP0008877_abnormal_DNA_methylation | 1.03706900 |
| 58 | MP0003633_abnormal_nervous_system | 1.01265592 |
| 59 | MP0004742_abnormal_vestibular_system | 0.97961246 |
| 60 | MP0001986_abnormal_taste_sensitivity | 0.97260298 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 0.97214547 |
| 62 | MP0002229_neurodegeneration | 0.96803595 |
| 63 | MP0003121_genomic_imprinting | 0.95132828 |
| 64 | MP0005253_abnormal_eye_physiology | 0.94856815 |
| 65 | MP0002069_abnormal_eating/drinking_beha | 0.94151664 |
| 66 | MP0003631_nervous_system_phenotype | 0.94009637 |
| 67 | MP0008961_abnormal_basal_metabolism | 0.93625762 |
| 68 | MP0000013_abnormal_adipose_tissue | 0.92068208 |
| 69 | MP0004142_abnormal_muscle_tone | 0.91775322 |
| 70 | MP0003861_abnormal_nervous_system | 0.89703231 |
| 71 | MP0002928_abnormal_bile_duct | 0.86259720 |
| 72 | MP0002160_abnormal_reproductive_system | 0.85624874 |
| 73 | MP0004043_abnormal_pH_regulation | 0.85557649 |
| 74 | MP0002752_abnormal_somatic_nervous | 0.84728166 |
| 75 | MP0008789_abnormal_olfactory_epithelium | 0.82798804 |
| 76 | MP0006072_abnormal_retinal_apoptosis | 0.80896868 |
| 77 | MP0004147_increased_porphyrin_level | 0.78449163 |
| 78 | MP0001963_abnormal_hearing_physiology | 0.77958302 |
| 79 | MP0004133_heterotaxia | 0.77744595 |
| 80 | MP0002837_dystrophic_cardiac_calcinosis | 0.76528029 |
| 81 | MP0003634_abnormal_glial_cell | 0.76042938 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.75276367 |
| 83 | MP0004085_abnormal_heartbeat | 0.74950860 |
| 84 | MP0001485_abnormal_pinna_reflex | 0.74739381 |
| 85 | MP0008872_abnormal_physiological_respon | 0.74525919 |
| 86 | MP0005551_abnormal_eye_electrophysiolog | 0.74274872 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 0.73747460 |
| 88 | MP0004145_abnormal_muscle_electrophysio | 0.73584525 |
| 89 | MP0003632_abnormal_nervous_system | 0.72485459 |
| 90 | MP0002234_abnormal_pharynx_morphology | 0.72451588 |
| 91 | MP0000427_abnormal_hair_cycle | 0.72133711 |
| 92 | MP0000026_abnormal_inner_ear | 0.71752536 |
| 93 | MP0003698_abnormal_male_reproductive | 0.70705622 |
| 94 | MP0001664_abnormal_digestion | 0.70215043 |
| 95 | MP0002102_abnormal_ear_morphology | 0.69784077 |
| 96 | MP0003123_paternal_imprinting | 0.69567078 |
| 97 | MP0000566_synostosis | 0.68641677 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.67447035 |
| 99 | MP0005195_abnormal_posterior_eye | 0.66037389 |
| 100 | MP0005535_abnormal_body_temperature | 0.65014609 |
| 101 | MP0001177_atelectasis | 0.64423536 |
| 102 | MP0005084_abnormal_gallbladder_morpholo | 0.63927660 |
| 103 | MP0004215_abnormal_myocardial_fiber | 0.63346650 |
| 104 | MP0003137_abnormal_impulse_conducting | 0.63227383 |
| 105 | MP0008874_decreased_physiological_sensi | 0.62918984 |
| 106 | MP0003938_abnormal_ear_development | 0.60878775 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.60273871 |
| 108 | MP0004233_abnormal_muscle_weight | 0.59240714 |
| 109 | MP0000604_amyloidosis | 0.58664862 |
| 110 | MP0001943_abnormal_respiration | 0.58366575 |
| 111 | MP0004510_myositis | 0.55203845 |
| 112 | MP0001348_abnormal_lacrimal_gland | 0.54620614 |
| 113 | MP0010769_abnormal_survival | 0.54421143 |
| 114 | MP0010770_preweaning_lethality | 0.54420757 |
| 115 | MP0002082_postnatal_lethality | 0.54420757 |
| 116 | MP0003956_abnormal_body_size | 0.53072221 |
| 117 | MP0002751_abnormal_autonomic_nervous | 0.52437449 |
| 118 | MP0003890_abnormal_embryonic-extraembry | 0.51742838 |
| 119 | MP0010768_mortality/aging | 0.51637969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.36220973 |
| 2 | Myokymia (HP:0002411) | 5.59780743 |
| 3 | Focal seizures (HP:0007359) | 5.24360841 |
| 4 | Visual hallucinations (HP:0002367) | 5.01017254 |
| 5 | Atonic seizures (HP:0010819) | 4.32788197 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.20208499 |
| 7 | Absence seizures (HP:0002121) | 3.85576511 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 3.73903235 |
| 9 | Febrile seizures (HP:0002373) | 3.67641818 |
| 10 | Broad-based gait (HP:0002136) | 3.56468300 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.46417374 |
| 12 | Mutism (HP:0002300) | 3.45052146 |
| 13 | Dialeptic seizures (HP:0011146) | 3.43862140 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.39331272 |
| 15 | Ankle clonus (HP:0011448) | 3.39051899 |
| 16 | Amyotrophic lateral sclerosis (HP:0007354) | 3.36038249 |
| 17 | Papilledema (HP:0001085) | 3.35876205 |
| 18 | Drooling (HP:0002307) | 3.28845890 |
| 19 | Excessive salivation (HP:0003781) | 3.28845890 |
| 20 | Poor eye contact (HP:0000817) | 3.11538791 |
| 21 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.04838757 |
| 22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.04775198 |
| 23 | Abnormality of the corticospinal tract (HP:0002492) | 3.04681676 |
| 24 | Termporal pattern (HP:0011008) | 3.04446181 |
| 25 | Insidious onset (HP:0003587) | 3.04446181 |
| 26 | Amblyopia (HP:0000646) | 3.04180746 |
| 27 | Truncal ataxia (HP:0002078) | 3.03859544 |
| 28 | Hyperventilation (HP:0002883) | 3.03153557 |
| 29 | Urinary urgency (HP:0000012) | 3.02335097 |
| 30 | Limb dystonia (HP:0002451) | 2.98528289 |
| 31 | Action tremor (HP:0002345) | 2.93242284 |
| 32 | Genetic anticipation (HP:0003743) | 2.88416038 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 2.87995711 |
| 34 | Epileptiform EEG discharges (HP:0011182) | 2.80129370 |
| 35 | Abnormality of the labia minora (HP:0012880) | 2.79979176 |
| 36 | Agitation (HP:0000713) | 2.75047554 |
| 37 | EEG with generalized epileptiform discharges (HP:0011198) | 2.74220565 |
| 38 | Type II lissencephaly (HP:0007260) | 2.72758605 |
| 39 | Depression (HP:0000716) | 2.70492777 |
| 40 | Abnormal social behavior (HP:0012433) | 2.69458673 |
| 41 | Impaired social interactions (HP:0000735) | 2.69458673 |
| 42 | Progressive inability to walk (HP:0002505) | 2.69333198 |
| 43 | Gaze-evoked nystagmus (HP:0000640) | 2.68176724 |
| 44 | Inappropriate behavior (HP:0000719) | 2.67624417 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.63713887 |
| 46 | Hypsarrhythmia (HP:0002521) | 2.63223443 |
| 47 | Anxiety (HP:0000739) | 2.60186810 |
| 48 | Dysmetria (HP:0001310) | 2.57888698 |
| 49 | Spastic gait (HP:0002064) | 2.55052308 |
| 50 | Medial flaring of the eyebrow (HP:0010747) | 2.52069529 |
| 51 | Abnormal eating behavior (HP:0100738) | 2.51017682 |
| 52 | Megalencephaly (HP:0001355) | 2.50537937 |
| 53 | Absent speech (HP:0001344) | 2.50421843 |
| 54 | Neurofibrillary tangles (HP:0002185) | 2.49491276 |
| 55 | Status epilepticus (HP:0002133) | 2.47164808 |
| 56 | Retinal dysplasia (HP:0007973) | 2.45514017 |
| 57 | Stereotypic behavior (HP:0000733) | 2.41947288 |
| 58 | Inability to walk (HP:0002540) | 2.41907482 |
| 59 | Pachygyria (HP:0001302) | 2.41715317 |
| 60 | Congenital primary aphakia (HP:0007707) | 2.41508786 |
| 61 | Dysdiadochokinesis (HP:0002075) | 2.40471661 |
| 62 | Abnormality of the lower motor neuron (HP:0002366) | 2.33537512 |
| 63 | Abnormality of binocular vision (HP:0011514) | 2.31600960 |
| 64 | Diplopia (HP:0000651) | 2.31600960 |
| 65 | Nephrogenic diabetes insipidus (HP:0009806) | 2.30617648 |
| 66 | Hemiparesis (HP:0001269) | 2.30197706 |
| 67 | Fetal akinesia sequence (HP:0001989) | 2.29124381 |
| 68 | Polyphagia (HP:0002591) | 2.28840572 |
| 69 | Spastic tetraplegia (HP:0002510) | 2.28219550 |
| 70 | Torticollis (HP:0000473) | 2.27730867 |
| 71 | Akinesia (HP:0002304) | 2.26933731 |
| 72 | Protruding tongue (HP:0010808) | 2.24029180 |
| 73 | Hypothermia (HP:0002045) | 2.22014447 |
| 74 | Nephronophthisis (HP:0000090) | 2.21652213 |
| 75 | Postural instability (HP:0002172) | 2.21248937 |
| 76 | Abnormality of salivation (HP:0100755) | 2.19988021 |
| 77 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.17310162 |
| 78 | Apathy (HP:0000741) | 2.17267052 |
| 79 | Gait imbalance (HP:0002141) | 2.17025112 |
| 80 | Pheochromocytoma (HP:0002666) | 2.17024296 |
| 81 | Poor suck (HP:0002033) | 2.16662324 |
| 82 | Sleep apnea (HP:0010535) | 2.15423603 |
| 83 | Genital tract atresia (HP:0001827) | 2.14841621 |
| 84 | Molar tooth sign on MRI (HP:0002419) | 2.13794875 |
| 85 | Abnormality of midbrain morphology (HP:0002418) | 2.13794875 |
| 86 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.13670578 |
| 87 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.13670578 |
| 88 | Papillary thyroid carcinoma (HP:0002895) | 2.12094828 |
| 89 | Vaginal atresia (HP:0000148) | 2.10200921 |
| 90 | Bradykinesia (HP:0002067) | 2.07701591 |
| 91 | Pancreatic cysts (HP:0001737) | 2.06124634 |
| 92 | Ulnar claw (HP:0001178) | 2.05563312 |
| 93 | Hypoplasia of the brainstem (HP:0002365) | 2.04716546 |
| 94 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.04716546 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.02863164 |
| 96 | Focal dystonia (HP:0004373) | 2.02479363 |
| 97 | Neuroendocrine neoplasm (HP:0100634) | 2.01515724 |
| 98 | Lower limb muscle weakness (HP:0007340) | 2.01332316 |
| 99 | Blue irides (HP:0000635) | 2.01116604 |
| 100 | Generalized myoclonic seizures (HP:0002123) | 1.98199781 |
| 101 | Scanning speech (HP:0002168) | 1.98159350 |
| 102 | Sporadic (HP:0003745) | 1.90857123 |
| 103 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.89219872 |
| 104 | Exotropia (HP:0000577) | 1.88697686 |
| 105 | Diminished motivation (HP:0000745) | 1.88455682 |
| 106 | Specific learning disability (HP:0001328) | 1.87360083 |
| 107 | Muscular hypotonia of the trunk (HP:0008936) | 1.86471275 |
| 108 | Obstructive sleep apnea (HP:0002870) | 1.85873260 |
| 109 | Craniofacial dystonia (HP:0012179) | 1.85284285 |
| 110 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.84793700 |
| 111 | Insomnia (HP:0100785) | 1.84584380 |
| 112 | Failure to thrive in infancy (HP:0001531) | 1.82515748 |
| 113 | Impaired vibratory sensation (HP:0002495) | 1.82253718 |
| 114 | Intention tremor (HP:0002080) | 1.81553139 |
| 115 | Esotropia (HP:0000565) | 1.81046569 |
| 116 | True hermaphroditism (HP:0010459) | 1.80874072 |
| 117 | Aqueductal stenosis (HP:0002410) | 1.80436505 |
| 118 | Dyskinesia (HP:0100660) | 1.80150152 |
| 119 | Lissencephaly (HP:0001339) | 1.80013212 |
| 120 | Pendular nystagmus (HP:0012043) | 1.78971651 |
| 121 | Pointed chin (HP:0000307) | 1.78914268 |
| 122 | Oligodactyly (hands) (HP:0001180) | 1.78897756 |
| 123 | Dysmetric saccades (HP:0000641) | 1.78741595 |
| 124 | Clonus (HP:0002169) | 1.78219762 |
| 125 | Abolished electroretinogram (ERG) (HP:0000550) | 1.77407266 |
| 126 | Poor coordination (HP:0002370) | 1.76540248 |
| 127 | Hyperthyroidism (HP:0000836) | 1.76537346 |
| 128 | Gait ataxia (HP:0002066) | 1.76492015 |
| 129 | CNS hypomyelination (HP:0003429) | 1.75233859 |
| 130 | Hypoplasia of the corpus callosum (HP:0002079) | 1.74163239 |
| 131 | Decreased central vision (HP:0007663) | 1.73618135 |
| 132 | Pancreatic fibrosis (HP:0100732) | 1.73463797 |
| 133 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.72623482 |
| 134 | Intellectual disability, severe (HP:0010864) | 1.72564274 |
| 135 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.72490642 |
| 136 | Prolonged QT interval (HP:0001657) | 1.72266129 |
| 137 | Paraplegia (HP:0010550) | 1.72122415 |
| 138 | Abnormality of the renal medulla (HP:0100957) | 1.68571190 |
| 139 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.65734855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.96195233 |
| 2 | MAP3K9 | 4.05067062 |
| 3 | NTRK3 | 3.87953722 |
| 4 | EPHA4 | 3.45886295 |
| 5 | MAP3K4 | 3.25811390 |
| 6 | MAP2K7 | 2.60924673 |
| 7 | MINK1 | 2.60727453 |
| 8 | NTRK2 | 2.27695756 |
| 9 | KSR2 | 2.26531925 |
| 10 | KSR1 | 2.01414925 |
| 11 | PAK6 | 2.01344952 |
| 12 | MAPK13 | 1.98381707 |
| 13 | PINK1 | 1.97876102 |
| 14 | TRIM28 | 1.93492360 |
| 15 | SIK2 | 1.90955090 |
| 16 | DAPK2 | 1.88363105 |
| 17 | RIPK4 | 1.78128937 |
| 18 | MAP2K4 | 1.74416288 |
| 19 | MAP3K12 | 1.72253412 |
| 20 | LATS2 | 1.70617038 |
| 21 | PNCK | 1.64853335 |
| 22 | PRKD3 | 1.64698422 |
| 23 | PLK2 | 1.64377192 |
| 24 | CASK | 1.61093980 |
| 25 | MAP3K2 | 1.57006937 |
| 26 | NTRK1 | 1.49834811 |
| 27 | ARAF | 1.49067964 |
| 28 | TNIK | 1.45068409 |
| 29 | CDK5 | 1.44913276 |
| 30 | BMPR2 | 1.39619511 |
| 31 | CAMKK1 | 1.35983546 |
| 32 | ADRBK2 | 1.29045798 |
| 33 | GRK5 | 1.26869387 |
| 34 | ERBB3 | 1.24896788 |
| 35 | TYRO3 | 1.24739985 |
| 36 | UHMK1 | 1.19802076 |
| 37 | DAPK1 | 1.17350974 |
| 38 | CSNK1G2 | 1.17033729 |
| 39 | EPHA3 | 1.13466032 |
| 40 | PRPF4B | 1.12485797 |
| 41 | PHKG1 | 1.12322976 |
| 42 | PHKG2 | 1.12322976 |
| 43 | MAP4K2 | 1.11976043 |
| 44 | RAF1 | 1.11763151 |
| 45 | DYRK2 | 1.10957298 |
| 46 | TAOK1 | 1.08850665 |
| 47 | RET | 1.07033093 |
| 48 | MAP3K6 | 1.02832764 |
| 49 | MAP3K13 | 0.95093285 |
| 50 | PRKCG | 0.94366965 |
| 51 | DYRK1A | 0.94021709 |
| 52 | CAMK2A | 0.91165822 |
| 53 | STK38 | 0.90910800 |
| 54 | MARK2 | 0.86857340 |
| 55 | FES | 0.86849021 |
| 56 | CDK19 | 0.85077276 |
| 57 | CDK14 | 0.82969741 |
| 58 | CAMKK2 | 0.82792375 |
| 59 | PAK3 | 0.82108140 |
| 60 | CDK18 | 0.81123390 |
| 61 | STK11 | 0.78932863 |
| 62 | CDK15 | 0.77804001 |
| 63 | GRK1 | 0.76397350 |
| 64 | FGR | 0.75871217 |
| 65 | CAMK2B | 0.69280300 |
| 66 | SCYL2 | 0.69265381 |
| 67 | SIK3 | 0.67459820 |
| 68 | CDK11A | 0.66507294 |
| 69 | WNK3 | 0.65157936 |
| 70 | SGK494 | 0.65121539 |
| 71 | SGK223 | 0.65121539 |
| 72 | EPHB2 | 0.65118421 |
| 73 | CSNK1G3 | 0.64013252 |
| 74 | PRKCH | 0.63231332 |
| 75 | STK39 | 0.60217148 |
| 76 | CAMK4 | 0.59166697 |
| 77 | ADRBK1 | 0.57069995 |
| 78 | SGK1 | 0.56830043 |
| 79 | LMTK2 | 0.55872721 |
| 80 | WNK4 | 0.55751721 |
| 81 | PRKCZ | 0.53591319 |
| 82 | CSNK1D | 0.52920449 |
| 83 | GRK7 | 0.52362568 |
| 84 | SGK2 | 0.51678181 |
| 85 | STK38L | 0.51386574 |
| 86 | TAOK3 | 0.51328618 |
| 87 | CSNK1A1L | 0.51130578 |
| 88 | ALK | 0.50444204 |
| 89 | PRKACA | 0.50008146 |
| 90 | PTK2B | 0.49476059 |
| 91 | CAMK2D | 0.48639559 |
| 92 | LIMK1 | 0.48320131 |
| 93 | CAMK2G | 0.46180175 |
| 94 | CAMK1 | 0.45416580 |
| 95 | BCR | 0.44940997 |
| 96 | MAP3K1 | 0.44792384 |
| 97 | CSNK1E | 0.44261615 |
| 98 | MAPK12 | 0.44156454 |
| 99 | RPS6KA2 | 0.44027288 |
| 100 | PRKG1 | 0.43678680 |
| 101 | MAPK10 | 0.42999691 |
| 102 | DMPK | 0.42045876 |
| 103 | PRKCI | 0.41923976 |
| 104 | DYRK3 | 0.40122590 |
| 105 | PRKAA1 | 0.40103937 |
| 106 | PRKCE | 0.39945897 |
| 107 | RPS6KA3 | 0.39903951 |
| 108 | MAP2K1 | 0.39618217 |
| 109 | PRKACB | 0.39169751 |
| 110 | BCKDK | 0.38584394 |
| 111 | CSNK1A1 | 0.37821602 |
| 112 | CSNK1G1 | 0.37502725 |
| 113 | BRAF | 0.36859841 |
| 114 | CAMK1G | 0.36852246 |
| 115 | PDK1 | 0.36599944 |
| 116 | FYN | 0.36221014 |
| 117 | RIPK1 | 0.35482125 |
| 118 | SGK3 | 0.35133048 |
| 119 | CDK3 | 0.34450650 |
| 120 | DYRK1B | 0.34449545 |
| 121 | PRKCA | 0.33941137 |
| 122 | CDC42BPA | 0.33211215 |
| 123 | TSSK6 | 0.32747608 |
| 124 | CCNB1 | 0.32600325 |
| 125 | NME1 | 0.32390160 |
| 126 | FRK | 0.32241839 |
| 127 | INSRR | 0.31896259 |
| 128 | PDPK1 | 0.31297567 |
| 129 | BMPR1B | 0.31075002 |
| 130 | MAP2K6 | 0.29567117 |
| 131 | FGFR2 | 0.28622742 |
| 132 | PRKCB | 0.28577844 |
| 133 | MAPK9 | 0.27316749 |
| 134 | OXSR1 | 0.26481354 |
| 135 | PKN1 | 0.26138578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.38306912 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.90814025 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.73618577 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.65673110 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.56508132 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.53796712 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.47490649 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.45749652 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.44577070 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.35669615 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.34497971 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.10327830 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.07001854 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.05360489 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.01456770 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.91340468 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.83041720 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.81483488 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.79381499 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.72953579 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71081902 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.71044566 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67642776 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.67031244 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.59989532 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.54480601 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.54220559 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.53289678 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.42704744 |
| 30 | Axon guidance_Homo sapiens_hsa04360 | 1.39438174 |
| 31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.33548037 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30143873 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.29553607 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29027364 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.28399760 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27745834 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22230389 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19049041 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.18733746 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.16396663 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 1.16369134 |
| 42 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.16259462 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.14586110 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12147316 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08200279 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 1.08095999 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.01127602 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00343768 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97761191 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97509327 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 0.96123514 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.96029901 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94525516 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92779499 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92527892 |
| 56 | Endometrial cancer_Homo sapiens_hsa05213 | 0.90523839 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89106230 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89105912 |
| 59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.88784785 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87652536 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85059878 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 0.84369539 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84194482 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.84029197 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83751146 |
| 66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83006954 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81935064 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80674689 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80608625 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80249563 |
| 71 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79533408 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79084782 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79060304 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78411398 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77355236 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76264917 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75691673 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75091904 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74541111 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73864972 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73711886 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72687391 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.72616311 |
| 84 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.70824956 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70525794 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69992749 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.69234041 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67772966 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67389301 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65805414 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65269929 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64894304 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64470216 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64456295 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64075130 |
| 96 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.63841386 |
| 97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.63787345 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61672127 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59901805 |
| 100 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59400194 |
| 101 | Protein export_Homo sapiens_hsa03060 | 0.58939847 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58763873 |
| 103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58638111 |
| 104 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58017995 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57662419 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56501707 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56071050 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55500420 |
| 109 | Histidine metabolism_Homo sapiens_hsa00340 | 0.55013785 |
| 110 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54806292 |
| 111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54313220 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53652456 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53440730 |
| 114 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52874516 |
| 115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52639105 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51960699 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49122580 |
| 118 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48814961 |
| 119 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48498086 |
| 120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47232160 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46173847 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44731780 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44705559 |
| 124 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43720558 |
| 125 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43638907 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.43107921 |
| 127 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.43095896 |
| 128 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42690151 |
| 129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42378347 |
| 130 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42218084 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.41609377 |
| 132 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40969101 |
| 133 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39409447 |
| 134 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37913762 |
| 135 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37728210 |
| 136 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37477764 |
| 137 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37413309 |
| 138 | ABC transporters_Homo sapiens_hsa02010 | 0.36507957 |
| 139 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33961191 |
| 140 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33420755 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.30507562 |
| 142 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.29966048 |
| 143 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28866069 |

